Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Numinus Wellness Inc (LKYSF)

Numinus Wellness Inc (LKYSF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.17
Trade LKYSF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7000 +21.43%
on 05/28/21
0.9000 -5.56%
on 05/24/21
+0.0955 (+12.66%)
since 05/11/21
3-Month
0.5900 +44.07%
on 04/21/21
1.2050 -29.46%
on 03/15/21
-0.2800 (-24.78%)
since 03/11/21
52-Week
0.1053 +707.22%
on 08/26/20
1.9300 -55.96%
on 12/15/20
+0.4188 (+97.12%)
since 06/11/20

Most Recent Stories

More News
Why the North America Psychedelic Drugs Market is Expected to Grow With the Fastest CAGR for Next Several Years

/PRNewswire/ -- The illegal drugs of the 1960's are becoming highly valued drugs for various new therapeutic uses across a growing list of maladies. The door of previously prohibited drugs has been opening...

SILO : 0.2846 (-1.79%)
CMPS : 39.68 (+0.71%)
MNMD : 3.92 (+8.29%)
CLXPF : 1.5297 (+3.36%)
LKYSF : 0.8500 (+1.25%)
NUMI.VN : 1.030 (+0.98%)
OPTI.CN : 0.700 (-2.78%)
OPTHF : 0.5875 (-0.94%)
Psychedelic Drug Market Has Become a Billion Dollar Industry As Acceptable Treatments Expand

, /PRNewswire/ -- Recently, the use of psychedelics is evolving for the treatment of a variety of mental illnesses, including anxiety, depression, post-traumatic stress disorder and other related uses....

LKYSF : 0.8500 (+1.25%)
SILO : 0.2846 (-1.79%)
CMPS : 39.68 (+0.71%)
MNMD : 3.92 (+8.29%)
NUMI.VN : 1.030 (+0.98%)
CLXPF : 1.5297 (+3.36%)
Top Mushroom Stocks Sprouting on the Health and Witness Trend

Now more than ever, millions of people are focused on their health and wellness. It’s why many ...

HAVLF : 0.5583 (+0.41%)
HALO : 42.79 (+2.56%)
HCANF : 0.0540 (-1.82%)
NUMI.VN : 1.030 (+0.98%)
LKYSF : 0.8500 (+1.25%)
CMPS : 39.68 (+0.71%)
PSYCF : 0.2262 (-8.75%)
HAVN.CN : 0.680 (unch)
PSYC.CN : 0.270 (-10.00%)
Psilocybin May Be Helpful for Those with Traumatic Brain Injury

Psilocybin could be a real game changer. Not only could it help with depression, anxiety, OCD, opioid ...

MNMD : 3.92 (+8.29%)
CMPS : 39.68 (+0.71%)
NUMI.VN : 1.030 (+0.98%)
LKYSF : 0.8500 (+1.25%)
RVVTF : 0.3821 (+2.58%)
PHRM.CN : 0.610 (+3.39%)
PHRRF : 0.4929 (+0.59%)
RVV.CN : 0.470 (+3.30%)
With Number Of Depression Cases Rising, Psilocybin Medicines Are Being Rapidly Accepted

, /PRNewswire/ -- Global Psychedelic and Psilocybin Drugs market is growing rapidly due to the increasing number of depression cases and rising special designation from the regulatory authorities to...

LKYSF : 0.8500 (+1.25%)
SILO : 0.2846 (-1.79%)
MYCOF : 0.2568 (+4.01%)
CMPS : 39.68 (+0.71%)
MMEDF : 4.6900 (+33.24%)
NUMI.VN : 1.030 (+0.98%)
Psychedelic Drugs Market Size Is Projected To Reach $10.75 Billion By 2027

, /PRNewswire/ -- The psychedelics industry has entered the spotlight! The rapidly increasing acceptance of psychedelic treatments is creating a strong demand from therapists and patients for access to ...

MCUR.CN : 0.395 (+6.76%)
MCURF : 0.3290 (+4.74%)
MMEDF : 4.6900 (+33.24%)
LKYSF : 0.8500 (+1.25%)
NUMI.VN : 1.030 (+0.98%)
FTRPF : 5.2000 (+2.97%)
FTRP.CN : 5.550 (+1.46%)
CLXPF : 1.5297 (+3.36%)
Psychedelics Could Play a Crucial Role in Your Mental Health Treatment

Psychedelics have become the new mental health buzzword. With clinical trials supporting psychedelic ...

CLXPF : 1.5297 (+3.36%)
MMEDF : 4.6900 (+33.24%)
ENBI.CN : 0.520 (-3.70%)
ENTBF : 0.4020 (-8.86%)
NUMI.VN : 1.030 (+0.98%)
LKYSF : 0.8500 (+1.25%)
PSYCF : 0.2262 (-8.75%)
PSYC.CN : 0.270 (-10.00%)
Industry Leaders Look To Artificial Intelligence To Drive Advancements In Mental Healthcare

Prominent mental healthcare conditions including anxiety, depression, and PTSD have historically required ...

MCURF : 0.3290 (+4.74%)
MMEDF : 4.6900 (+33.24%)
NUMI.VN : 1.030 (+0.98%)
LKYSF : 0.8500 (+1.25%)
FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.2000 (+2.97%)
CLXPF : 1.5297 (+3.36%)
MCUR.CN : 0.395 (+6.76%)
Biotech Companies Driving Psychedelics Industry Forward with Key Research

, /PRNewswire/ -- As an urgent public mental health crisis forces research institutions and governments to seriously examine unconventional mental health solutions, psychedelic assisted therapies are...

CMPS : 39.68 (+0.71%)
MYCOF : 0.2568 (+4.01%)
NUMI.VN : 1.030 (+0.98%)
LKYSF : 0.8500 (+1.25%)
MINE : 0.0017 (-37.04%)
SEEL : 3.36 (+0.60%)
Music May Play a Critical Role in Psychedelic Therapy Sessions

When it comes to psychedelic therapy, music may heighten the benefit. For example, studies have shown ...

CLXPF : 1.5297 (+3.36%)
MMEDF : 4.6900 (+33.24%)
NUMI.VN : 1.030 (+0.98%)
LKYSF : 0.8500 (+1.25%)
FTRPF : 5.2000 (+2.97%)
NMDBF : 0.1192 (-3.95%)
FTRP.CN : 5.550 (+1.46%)
NEON.CN : 0.145 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.9630
2nd Resistance Point 0.9204
1st Resistance Point 0.8852
Last Price 0.8500
1st Support Level 0.8074
2nd Support Level 0.7648
3rd Support Level 0.7296

See More

52-Week High 1.9300
Fibonacci 61.8% 1.2330
Fibonacci 50% 1.0177
Last Price 0.8500
Fibonacci 38.2% 0.8023
52-Week Low 0.1053

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar